PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3029% below fair value

$16.24+0.06 (+0.37%)

Close on Nov 13, 2026Market cap $2.25BP/E –Yield 7.14%

Earnings

Perrigo's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 25, 2027

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$989.00M

-4.9% on a year earlier

All In adjusted diluted EPS, Q3 FY2026

$0.60

$0.80 a year earlier

Latest guidance

Raised

Nov 4, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Perrigo's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 25, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 26, 2026	Nov 4, 2026before the open	$989.00M	-4.9%	-$0.10	$0.60	Release
Q2 FY2026ended Jun 27, 2026	Aug 5, 2026before the open	$1.02B	-3.8%	–	–	Release
Q1 FY2026ended Mar 28, 2026	May 6, 2026before the open	$969.00M	-6.8%	-$2.81	$0.43	Release
Q4 FY2025ended Dec 31, 2025	Feb 26, 2026before the open	$1.11B	-2.6%	-$10.20	$0.77	Release
Q3 FY2025ended Sep 27, 2025	Nov 5, 2025before the open	$1.04B	-5.5%	$0.09	$0.80	Release
Q2 FY2025ended Jun 28, 2025	Aug 6, 2025before the open	$1.06B	-3.6%	$0.00	$0.57	Release
Q1 FY2025ended Mar 29, 2025	May 7, 2025before the open	$1.04B	-5.5%	$0.00	$0.60	Release
Q4 FY2024ended Dec 31, 2024	Feb 27, 2025during market hours	$1.14B	-5.0%	-$0.30	$0.93	Release
Q3 FY2024ended Sep 28, 2024	Nov 6, 2024before the open	$1.10B	0.0%	-$0.13	$0.81	Release
Q2 FY2024ended Jun 29, 2024	Aug 2, 2024before the open	$1.10B	-8.3%	-$0.77	$0.53	Release
Q1 FY2024ended Mar 30, 2024	May 7, 2024before the open	$1.10B	-8.3%	$0.03	$0.29	Release
Q4 FY2023ended Dec 31, 2023	Feb 27, 2024before the open	$1.20B	0.0%	-$0.20	$0.86	Release
Q3 FY2023ended Sep 30, 2023	Nov 7, 2023before the open	$1.10B	0.0%	$0.11	$0.64	Release
Q2 FY2023ended Jul 1, 2023	Aug 8, 2023before the open	$1.20B	+9.1%	$0.06	$0.63	Release
Q1 FY2023ended Apr 1, 2023	May 9, 2023before the open	$1.20B	+9.1%	-$0.01	$0.45	Release
Q4 FY2022ended Dec 31, 2022	Feb 27, 2023during market hours	$1.20B	+9.1%	-$0.09	$0.75	Release
Q3 FY2022ended Oct 1, 2022	Nov 8, 2022before the open	$1.10B	+5.8%	-$0.39	$0.56	Release
Q2 FY2022ended Jul 2, 2022	Aug 9, 2022before the open	$1.10B	–	-$0.48	$0.43	Release
Q1 FY2022ended Apr 2, 2022	May 11, 2022before the open	$1.10B	–	-$0.01	$0.33	Release
Q4 FY2021ended Dec 31, 2021	Mar 1, 2022before the open	$1.10B	–	$0.24	$0.60	Release
Q3 FY2021ended Oct 2, 2021	Nov 10, 2021before the open	$1.04B	–	-$0.40	$0.45	Release
Q2 FY2021ended Jul 3, 2021	Aug 11, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Apr 3, 2021	May 11, 2021before the open	–	–	–	–	Release
Q4 FY2020ended Dec 31, 2020	Mar 1, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 26, 2020	Nov 4, 2020during market hours	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Perrigo's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
net sales growth	FY2026	-5.5% – -1.5%	–	New	Feb 26, 2026
Net Sales Growth YoYGAAP	FY2026	-5.7% – -4.6%	-5.5% – -1.5%	Lowered	Nov 4, 2026
Organic Core Net Sales Growthnon-GAAP	FY2026	-3.5% – +0.5%	–	Lowered	Aug 5, 2026
Adj. Gross Marginnon-GAAP	FY2026	37.8% – 38.8%	36.5% – 37.5%	Raised	Nov 4, 2026
Adj. Gross Margin (Core)non-GAAP	FY2026	39% – 40%	36.5% – 37.5%	Reaffirmed	Aug 5, 2026
Adj. Operating Marginnon-GAAP	FY2026	14.3% – 15.3%	12.5% – 13.5%	Raised	Nov 4, 2026
Adj. Operating Margin (Core)non-GAAP	FY2026	15% – 16%	12.5% – 13.5%	Reaffirmed	Aug 5, 2026
Adj. EPSnon-GAAP	FY2026	$2.25 – $2.45	$2.00 – $2.30	Raised	Nov 4, 2026
Adj. EPS (Core)non-GAAP	FY2026	$2.25 – $2.55	$2.00 – $2.30	Reaffirmed	Aug 5, 2026
Adjusted effective tax ratenon-GAAP	FY2026	18%	20%	Lowered	Aug 5, 2026
Adjusted weighted average shares outstandingnon-GAAP	FY2026	139.3	140.5	Lowered	Aug 5, 2026
Interest expense	FY2026	$156.00M	–	New	Feb 26, 2026
Net interest expensenon-GAAP	FY2026	$156.00M	–	New	Aug 5, 2026
Net leveragenon-GAAP	FY2026	4	4	Reaffirmed	Aug 5, 2026

Guidance vs results

The last range Perrigo gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Adjusted diluted EPS	$2.70 – $2.80	$2.74Σ4Q	Within range
FY2025	Revenue growth	-3% – -2.5%	-4.28%Σ4Q	Below range

Guidance history

Every forecast Perrigo put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 4, 2026	Adj. EPS	FY2026	$2.25 – $2.45	Raised
Nov 4, 2026	Adj. Gross Margin	FY2026	37.8% – 38.8%	Raised
Nov 4, 2026	Adj. Operating Margin	FY2026	14.3% – 15.3%	Raised
Nov 4, 2026	Net Sales Growth YoY	FY2026	-5.7% – -4.6%	Lowered
Aug 5, 2026	Adj. EPS (Core)	FY2026	$2.25 – $2.55	Reaffirmed
Aug 5, 2026	Adj. Gross Margin (Core)	FY2026	39% – 40%	Reaffirmed
Aug 5, 2026	Adj. Operating Margin (Core)	FY2026	15% – 16%	Reaffirmed
Aug 5, 2026	Net leverage	FY2026	4	Reaffirmed
Aug 5, 2026	Adjusted effective tax rate	FY2026	18%	Lowered
Aug 5, 2026	Adjusted weighted average shares outstanding	FY2026	139.3	Lowered
Aug 5, 2026	Net interest expense	FY2026	$156.00M	New
Aug 5, 2026	Organic Core Net Sales Growth	FY2026	-3.5% – +0.5%	Lowered
Aug 5, 2026	Net Sales Growth (Core)	FY2026	-3% – +1%	New
May 6, 2026	Adj. EPS	FY2026	$2.00 – $2.30	New
May 6, 2026	Adj. Gross Margin	FY2026	36.5% – 37.5%	New
May 6, 2026	Adj. Operating Margin	FY2026	12.5% – 13.5%	New
May 6, 2026	Net Sales Growth	FY2026	-5.5% – -1.5%	New
Feb 26, 2026	adjusted diluted EPS	FY2026	$2.00 – $2.30	New
Feb 26, 2026	CORE adjusted EPS	FY2026	$2.25 – $2.55	Raised
Feb 26, 2026	Adj. Gross Margin	FY2026	36.5% – 37.5%	New
Feb 26, 2026	Adj. Gross Margin	FY2026	39% – 40%	Raised
Feb 26, 2026	Adj. Operating Margin	FY2026	12.5% – 13.5%	New
Feb 26, 2026	Adj. Operating Margin	FY2026	15% – 16%	Raised
Feb 26, 2026	Interest expense	FY2026	$156.00M	New
Feb 26, 2026	Adjusted effective tax rate	FY2026	20%	New
Feb 26, 2026	Adjusted weighted average shares outstanding	FY2026	140.5	New
Feb 26, 2026	Net leverage	FY2026	4	New
Feb 26, 2026	net sales growth	FY2026	-5.5% – -1.5%	New
Nov 5, 2025	Adjusted diluted EPS	FY2025	$2.70 – $2.80	New
Nov 5, 2025	Adjusted gross margin	FY2025	39%	New
Nov 5, 2025	Adjusted operating margin	FY2025	15%	New
Nov 5, 2025	Interest expense	FY2025	$155.00M	New
Nov 5, 2025	Adjusted weighted average shares outstanding	FY2025	138.5	New
Nov 5, 2025	Net leverage	FY2025	3.8	New
Nov 5, 2025	Adjusted effective tax rate	FY2025	18.5%	New
Nov 5, 2025	Organic net sales growth	FY2025	-2.5% – -2%	New
Nov 5, 2025	Reported net sales growth	FY2025	-3% – -2.5%	New
Aug 6, 2025	Adjusted diluted EPS range	FY2025	$2.90 – $3.10	Reaffirmed
Aug 6, 2025	Free cash flow as a percentage of net sales	FY2025	6%	Reaffirmed
Aug 6, 2025	Adjusted gross margin	FY2025	40%	Reaffirmed
Aug 6, 2025	Adjusted operating margin	FY2025	15%	Reaffirmed
Aug 6, 2025	Net leverage	FY2025	3.5	Reaffirmed
Aug 6, 2025	Operating cash flow conversion to adjusted net income	FY2025	100%	New
Aug 6, 2025	Organic net sales growth	FY2025	+1.5% – +4.5%	Reaffirmed
Aug 6, 2025	Reported net sales growth	FY2025	0% – +3%	New
May 7, 2025	Adjusted diluted earnings per share ("EPS")	FY2025	$2.90 – $3.10	New
May 7, 2025	Free cash flow as a percentage of net sales	FY2025	6%	New
May 7, 2025	Adjusted gross margin	FY2025	40%	New
May 7, 2025	Adjusted operating margin	FY2025	15%	New
May 7, 2025	Net leverage	FY2025	3.5	New
May 7, 2025	Reported net sales growth	FY2025	0% – +3%	New
May 7, 2025	Organic net sales growth	FY2025	+1.5% – +4.5%	New
Nov 6, 2024	adjusted diluted EPS outlook	FY2024	$2.50 – $2.65	Reaffirmed
Nov 6, 2024	Operating cash flow conversion	FY2024	90% – 100%	Raised
Nov 6, 2024	Interest expense	FY2024	$180.00M	Reaffirmed
Nov 6, 2024	Full year adjusted tax rate	FY2024	19% – 20%	Lowered
Nov 6, 2024	total net sales growth outlook	FY2024	-5% – -3%	Reaffirmed
Nov 6, 2024	organic net sales growth outlook	FY2024	-3% – -1%	Reaffirmed
Aug 2, 2024	adjusted diluted EPS outlook	FY2024	$2.50 – $2.65	Reaffirmed
Aug 2, 2024	organic net sales growth outlook	FY2024	-3% – -1%	Lowered
Aug 2, 2024	total net sales growth outlook	FY2024	-5% – -3%	New
May 7, 2024	adjusted diluted EPS	FY2024	$2.50 – $2.65	Reaffirmed
May 7, 2024	adjusted tax rate	FY2024	20.5%	Lowered
May 7, 2024	Operating cash flow conversion	FY2024	90% – 100%	Raised
May 7, 2024	Interest expense	FY2024	$180.00M	Reaffirmed
May 7, 2024	organic net sales	FY2024	+1% – +3%	Reaffirmed
Feb 27, 2024	Adjusted diluted EPS	FY2024	$2.50 – $2.65	New
Feb 27, 2024	Interest expense	FY2024	$180.00M	New
Feb 27, 2024	Full year adjusted tax rate	FY2024	20.5%	New
Feb 27, 2024	Operating cash flow conversion	FY2024	90% – 100%	Raised
Feb 27, 2024	Organic net sales growth	FY2024	+1% – +3%	New
Nov 7, 2023	Adjusted diluted EPS	FY2023	$2.50 – $2.60	Lowered
Nov 7, 2023	Reported Diluted EPS	FY2023	$0.40 – $0.50	Lowered
Nov 7, 2023	Operating cash flow conversion	FY2023	100%	Raised
Nov 7, 2023	Interest expense	FY2023	$180.00M	Reaffirmed
Nov 7, 2023	Full year adjusted tax rate	FY2023	14%	Lowered
Nov 7, 2023	Organic net sales growth	FY2023	+1% – +3%	Lowered
Nov 7, 2023	Reported net sales growth	FY2023	+4% – +6%	Lowered
Aug 8, 2023	Adjusted diluted EPS	FY2023	$2.50 – $2.70	Reaffirmed
Aug 8, 2023	Reported Diluted EPS	FY2023	$0.50 – $0.70	New
Aug 8, 2023	Adjusted tax rate	FY2023	19.5%	Lowered
Aug 8, 2023	Interest expense	FY2023	$180.00M	Reaffirmed
Aug 8, 2023	Operating cash flow conversion	FY2023	100%	New
Aug 8, 2023	full year adjusted tax rate	FY2023	17%	Lowered
Aug 8, 2023	Reported net sales growth	FY2023	+7% – +11%	Reaffirmed
Aug 8, 2023	Organic net sales growth	FY2023	+3% – +6%	Reaffirmed
May 9, 2023	Non-GAAP (“adjusted”) diluted EPS	FY2023	$2.50 – $2.70	New
May 9, 2023	Adjusted tax expense rate	FY2023	21.5%	New
May 9, 2023	Cash conversion (operating cash flow as a percentage of adjusted net income)	FY2023	100%	Raised
May 9, 2023	Interest expense	FY2023	$180.00M	New
May 9, 2023	Reported net sales growth	FY2023	+7% – +11%	New
May 9, 2023	Organic net sales growth	FY2023	+3% – +6%	New
Nov 8, 2022	adjusted EPS	FY2022	$2.00 – $2.10	Lowered
Nov 8, 2022	organic net sales growth	FY2022	+9% – +10%	Reaffirmed
Nov 8, 2022	total net sales growth	FY2022	+8.5% – +9.5%	Reaffirmed
Aug 9, 2022	adjusted EPS	FY2022	$2.25 – $2.35	Lowered
Aug 9, 2022	organic net sales growth	FY2022	+9% – +10%	Raised
Aug 9, 2022	total net sales growth	FY2022	+8.5% – +9.5%	Reaffirmed
May 11, 2022	adjusted EPS	FY2022	$2.30 – $2.40	Raised
May 11, 2022	adjusted effective tax rate	FY2022	23%	Lowered
May 11, 2022	net sales growth	FY2022	+8.5% – +9.5%	New
May 11, 2022	organic sales growth	FY2022	+8% – +9%	Raised
Mar 1, 2022	Adjusted diluted EPS	FY2022	$2.10 – $2.30	New
Mar 1, 2022	adjusted effective tax rate	FY2022	23%	New
Mar 1, 2022	Cash flow from operations as a percentage of adjusted net income	FY2022	95% – 105%	Raised
Mar 1, 2022	Interest/other expense	FY2022	$140.00M	New
Mar 1, 2022	Organic net sales growth	FY2022	+7% – +8%	New
Mar 1, 2022	Net sales growth	FY2022	+3.5% – +4.5%	New
Nov 10, 2021	adjusted diluted EPS	FY2021	$2.00 – $2.10	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.